Seeking Alpha

Clovis Oncology (CLVS) increases its stock offering to $240M from $170M, selling 3.33M shares at...

Clovis Oncology (CLVS) increases its stock offering to $240M from $170M, selling 3.33M shares at $72 each. There's also a greenshoe option of 486,110 shares. Clovis intends to use the money for general corporate purposes, including funding the company's development programs, and the acquisition or licensing of additional product candidates or businesses. Shares -2.1% at $73.30. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)